|
National Stock Number(NSN): 6505-00-728-0371 (6505007280371, 007280371)
| NIIN: |
00-728-0371 |
Item Name: |
DOCUSATE SODIUM SOLUTION |
INC: |
34114
|
| FSC: |
6505
|
Assignment Date: |
Jan-01-1961 |
CRIT: |
X |
IIG: |
34114 |
| ISC: |
5 |
Date Standardized: |
Feb-01-1975 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
U |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3004.90.9250 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
98 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
717-79 |
29398
|
MEAD JOHNSON & COMPANY, LLC |
H |
3 |
1 |
6 |
54 |
|
|
|
|
|
|
|
COLACE |
29398
|
MEAD JOHNSON & COMPANY, LLC |
H |
5 |
1 |
6 |
54 |
|
|
|
|
|
|
|
DISONATE |
82600
|
LANNETT COMPANY, INC. |
H |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
|
NDC00087-0717-04 |
29398
|
MEAD JOHNSON & COMPANY, LLC |
H |
3 |
2 |
6 |
75 |
|
|
|
|
|
|
|
NDC00121-0544-16 |
61181
|
PHARMACEUTICAL ASSOCIATES, INC. |
H |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
|
NDC00472-0936-16 |
57979
|
NATIONAL PHARMACEUTICAL MFG CO A DIV OF BARRE-NATIONAL INC SUB OF REVCO D S INC |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
NDC00527-0824-27 |
82600
|
LANNETT COMPANY, INC. |
H |
5 |
9 |
6 |
75 |
1 |
B |
|
|
|
|
|
NDC47679-0412-11 |
63998
|
BAXTER HEALTHCARE CORP PHARMACEUTICALS DIV |
H |
5 |
9 |
4 |
54 |
|
B |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
10.00 MILLIGRAMS DOCUSATE SODIUM PER MILLILITER |
| AKJQ |
PHARMACEUTICAL VEHICLE TYPE |
AQUEOUS |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
16.000 OUNCES |
| CSGS |
ADMINISTRATION |
ORAL |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|